Top

Archives of Gynecology and Obstetrics

Published in:

01-09-2012 | Letter to the Editor

Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour

Authors: Krista J. M. Stibbe, Sabina de Weerd

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Excerpt

To the editor, …

Honkanen H, Piaggio G, Hertzen H, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, Gopalan S, Horga M, Jerve F, Mittal S, Thi Nhu Ngoc N, Peregoudov A, Prasad RN, Pretnar-Darovec A, Shah RS, Song S, Tang OS, Wu SC (2004) WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. BJOG 111(7):715–725. doi:10.1111/j.1471-0528.2004.00153.x PubMedCrossRef

Feldman DM, Borgida AF, Rodis JF, Leo MV, Campbell WA (2003) A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol 189(3):710–713. pii:S0002937803006598PubMedCrossRef

Brouns JF, van Wely M, Burger MP, van Wijngaarden WJ (2010) Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination. Contraception 82(3):266–275. doi:S0010-7824(10)00096-X PubMedCrossRef

Ponce Gomez, de Leon R, Wing DA (2009) Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy—a systematic review. Contraception 79(4):259–271. doi:S0010-7824(08)00490-3 CrossRef

Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A (2002) Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG 109(4):443–447PubMedCrossRef

Vayrynen W, Heikinheimo O, Nuutila M (2007) Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstet Gynecol Scand 86(6):701–705. doi:10.1080/00016340701379853 PubMedCrossRef

el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332(15):983–987. doi:10.1056/NEJM199504133321502 PubMedCrossRef

Cabrol D, Dubois C, Cronje H, Gonnet JM, Guillot M, Maria B, Moodley J, Oury JF, Thoulon JM, Treisser A et al (1990) Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol 163(2):540–542PubMed

Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW (1997) Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 90(5):735–738. doi:10.1016/S0029-7844(97)00419-5 PubMedCrossRef

10.

Stoutjesdijk JA, Alsma J, Wildschut HI (2004) Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication ‘foetal congenital defects’; results of a retrospective study. Ned Tijdschr Geneeskd 148(26):1293–1296PubMed

Title: Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour
Authors: Krista J. M. Stibbe
Sabina de Weerd
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2289-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Efficacy of cryoanalgesia in decreasing pain during second trimester genetic amniocentesis: a randomized trial

Isolated contralateral groin relapse in vulvar cancer

Prevalence and type distribution of high-risk human papillomavirus infections among women in Wufeng County, China

Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis

Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas

Sister Mary Joseph’s nodule associated with rare endometrial squamous cell carcinoma